Get Fit Bharat

Tag: Active

HomeActive

NYAB announced on 12 November 2024 that Klas Rewelj has been appointed as Group CFO to succeed Aku Väliaho, who will leave the company to assume a position outside the Group. The change in the Executive Management Team has now come into effect. NYAB’s Executive Management Team consists of the …

Hong Kong:  The Society of Publishers in Asia (SOPA), a not-for-profit organization dedicated to encouraging the best practices within journalism, announced today that the SOPA 2025 Awards for Editorial Excellence are open for entries. The deadline for submissions is 3pm Hong Kong time on Thursday, February 13, 2025.   The …

The Association of People with Disability (APD) observed the International Day of Persons with Disabilities (IDPD) 2024 with a ‘Mela’ (fair) on Monday, December 9, at the India Campus Crusade for Christ, Hennur Main Road, Bengaluru. The Mela, themed “Championing Disability Leadership for a Sustainable Tomorrow,” focused on the role of persons with disabilities (PwDs) in …

Copenhagen, Denmark, 10 December 2024 - Curasight A/S ("Curasight" or the “Company" - TICKER: CURAS) hereby announces the outcome of the exercise of warrants of series TO2, which were issued in connection with Curasight A/S rights issue and directed issue of units earlier in 2024 (“TO2”). In total, 466,453 warrants of series …

Bengaluru, Karnataka, India RenaissThera Private Limited (“RenaissThera”), a pioneering Bengaluru-based biotechnology company, has successfully closed its seed funding round backed by angel investors. This funding will accelerate the development of novel small-molecule therapies targeting GLP-1 and GIP receptors for Cardio-metabolic (CM) diseases, with an emphasis on diabetes and obesity. The company aims to …

Neogap Therapeutics AB, a Swedish clinical-stage biotechnology company, announces that the European Medicines Agency (EMA) has granted Advanced Therapy Medicinal Product (ATMP) classification to its cell therapy, pTTL (personalised Tumour Trained Lymphocytes). This classification confirms that pTTL meets the regulatory criteria for a somatic cell therapy product, providing a clear regulatory …